Fresenius SE & Co KGaA (FRE) Given a €80.00 Price Target by Warburg Research Analysts

Fresenius SE & Co KGaA (FRA:FRE) received a €80.00 ($95.24) price target from research analysts at Warburg Research in a research report issued to clients and investors on Wednesday, December 27th. The firm currently has a “buy” rating on the stock. Warburg Research’s price objective indicates a potential upside of 22.77% from the company’s current price.

FRE has been the subject of several other reports. Deutsche Bank set a €84.00 ($100.00) target price on Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Friday, November 3rd. Oddo Bhf set a €82.00 ($97.62) target price on Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Friday, November 3rd. Berenberg Bank set a €89.10 ($106.07) target price on Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Thursday, November 2nd. Citigroup set a €83.00 ($98.81) target price on Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Tuesday, October 3rd. Finally, Goldman Sachs Group set a €78.00 ($92.86) target price on Fresenius SE & Co KGaA and gave the company a “neutral” rating in a research note on Wednesday, September 20th. One analyst has rated the stock with a sell rating, five have given a hold rating and eleven have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of €78.66 ($93.65).

Shares of Fresenius SE & Co KGaA (FRE) traded down €1.08 ($1.29) on Wednesday, hitting €65.16 ($77.57). The stock had a trading volume of 3,006 shares. The firm has a market cap of $35,910.00 and a P/E ratio of 20.75. Fresenius SE & Co KGaA has a 12 month low of €60.16 ($71.62) and a 12 month high of €80.00 ($95.24).

ILLEGAL ACTIVITY WARNING: “Fresenius SE & Co KGaA (FRE) Given a €80.00 Price Target by Warburg Research Analysts” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/01/12/fresenius-se-80-00-price-target-by-warburg-research-analysts-2.html.

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply